多中心随机临床试验:高交联聚乙烯与常规聚乙烯在518例初次全膝关节置换术10年随访中的比较
该多中心随机临床试验纳入518例(518膝)初次全膝关节置换术患者,比较高交联聚乙烯(HXLPE)与常规超高分子量聚乙烯(UHMWPE)衬垫的10年假体生存率、并发症、影像学结果和临床结局。平均随访11年,两组10年免于任何翻修和再手术的生存率分别为96%和94%,翻修或再手术风险无差异(p>0.05)。HXLPE组无因聚乙烯磨损、骨溶解或柱骨折导致的翻修,UHMWPE组有1例因骨溶解行髌骨骨折切开复位内固定。
要点
- 10年总体免于任何翻修生存率为96%,免于任何再手术生存率为94%。
- 两组翻修或再手术风险无差异(p>0.05),共19例翻修。
- HXLPE组无磨损相关失败,UHMWPE组有1例因骨溶解行髌骨骨折ORIF。
核心结论
- HXLPE组未发现磨损相关失败,但UHMWPE组有1例骨溶解。
研究设计与样本
- 多中心随机临床试验,纳入3个中心(属1个三级转诊网络)的518例(518膝)初次全膝关节置换术患者。
- 平均年龄67岁,平均体重指数32 kg/m²,58%为女性。
- 所有患者接受骨水泥固定后稳定型胫骨衬垫和髌骨表面置换。
- 采用分层动态分配随机化,患者对分组设盲;对照组254膝使用UHMWPE衬垫(N2Vac;Stryker),治疗组264膝使用HXLPE衬垫(X3;Stryker)。
- 评估Kaplan-Meier生存率、影像学结果和临床结局,平均随访11年。
主要发现
- 10年总体免于任何翻修生存率为96%,免于任何再手术生存率为94%。
- 两组翻修或再手术风险无差异(p>0.05)。
- 共19例翻修,翻修指征包括假体周围关节感染(14膝)、不稳定(4膝)和因UHMWPE衬垫周围骨溶解导致髌骨骨折行切开复位内固定(1膝)。
- HXLPE组无因聚乙烯磨损、骨溶解或柱骨折导致的翻修。
- 影像学结果和临床结局两组相似。
关键数值与推荐
- 10年免于任何翻修生存率96%,免于任何再手术生存率94%。
- 两组翻修或再手术风险无差异(p>0.05)。
- 共19例翻修:假体周围关节感染14膝,不稳定4膝,因UHMWPE衬垫周围骨溶解导致髌骨骨折行ORIF 1膝。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Second-generation highly cross-linked polyethylene (HXLPE) has revolutionized total hip arthroplasty. However, the long-term risks and benefits of HXLPE in primary total knee arthroplasty (TKA) remain unknown. This randomized clinical trial evaluated implant survivorship, complications, radiographic results, and clinical outcomes of HXLPE and conventional ultra-high molecular weight polyethylene (UHMWPE) inserts in primary TKAs. METHODS: We enrolled 518 patients (518 knees) who underwent primary TKA in 3 centers within 1 tertiary referral network. The mean age was 67 years, the mean body mass index was 32 kg/m 2 , and 58% of the patients were women. All of the patients underwent primary TKA with a cemented posterior-stabilized tibial insert and patellar resurfacing. Randomization proceeded via stratified dynamic allocation. The patients were blinded to their study group allocation: those in the control group (254 knees) underwent TKA with an UHMWPE insert (N2Vac; Stryker); those in the treatment group (264 knees) received an HXLPE insert (X3; Stryker). Kaplan-Meier survivorship, radiographic results, and clinical outcomes were assessed. This trial was registered with ClinicalTrials.gov. The mean follow-up was 11 years. RESULTS: The 10-year overall survivorship free from any revision and from any reoperation was 96% and 94%, respectively. There were no differences in the risk of revision or reoperation between the groups (p > 0.05). There were a total of 19 revisions. Revision indications included periprosthetic joint infection (14 knees), instability (4 knees), and open reduction and internal fixation (ORIF) for a patellar fracture due to osteolysis around a UHMWPE insert (1 knee). There were no revisions due to polyethylene wear, osteolysis, or fracture of the post in the HXLPE group. The radiographic results and clinical outcomes were otherwise similar. CONCLUSIONS: Notably, no wear-related failures were identified in the HXLPE group, but there was 1 case of osteolysis in the UHMWPE group. LEVEL OF EVIDENCE: Therapeutic Level I . See Instructions for Authors for a complete description of levels of evidence.
引用
- Salmons HI, Larson DR, Ortiguera CJ, et al. Multicenter Randomized Clinical Trial of Highly Cross-Linked Polyethylene Versus Conventional Polyethylene in 518 Primary TKAs at 10 Years. J Bone Joint Surg Am. 2024. PMID: 39504359. doi:10.2106/JBJS.24.00445
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。